{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:14:58Z","timestamp":1787026498151,"version":"build-2736575974"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Bullous pemphigoid (BP) is an autoimmune disease characterized by autoantibody-mediated activation of immune cells and subepidermal blister formation. Excess amounts of extracellular DNA are produced in BP, however, it remains unclear how extracellular DNA contributes to BP pathogenesis. Here we show a possible mechanism by which interleukin (IL)-26 binds to extracellular DNA released from neutrophils and eosinophils to support DNA sensing. Patients with BP exhibited high circulating levels of IL-26, forming IL-26\n                    <jats:bold>\u2013<\/jats:bold>\n                    DNA complexes in the upper dermis and inside the blisters. IL-26\n                    <jats:bold>\u2013<\/jats:bold>\n                    DNA complexes played a dual role in regulating local immunity and blister formation. First, they enhanced the production of inflammatory cytokines in monocytes and neutrophils. Second, and importantly, the complexes augmented the production and activity of proteases from co-cultured monocytes and neutrophils, which induced BP180 cleavage in keratinocytes and dermal-epidermal separation in a modified human cryosection model. Collectively, we propose a model in which IL-26 and extracellular DNA synergistically act on immune cells to enhance autoantibody-driven local immune responses and protease-mediated fragility of dermal-epidermal junction in BP.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2022.1013382","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T04:15:51Z","timestamp":1665375351000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Interleukin-26\u2013DNA complexes promote inflammation and dermal-epidermal separation in a modified human cryosection model of bullous pemphigoid"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuka","family":"Mizuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Taira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiki","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Awaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12484863","article-title":"Partial cDNA cloning of the 230-kD mouse bullous pemphigoid antigen by use of a human monoclonal anti-basement membrane zone antibody","volume":"95","author":"Amagai","year":"1990","journal-title":"J Invest Dermatol"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.136.4.1231","article-title":"Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting","volume":"136","author":"Labib","year":"1986","journal-title":"J Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113803","article-title":"Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies","volume":"82","author":"Stanley","year":"1988","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)55195-4","article-title":"Human bullous pemphigoid antigen (BPAG1). amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains","volume":"266","author":"Sawamura","year":"1991","journal-title":"J Biol Chem"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of autoantibody-induced pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117826","article-title":"The role of complement in experimental bullous pemphigoid","volume":"95","author":"Liu","year":"1995","journal-title":"J Clin Invest."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/path.1674","article-title":"Granulocyte-derived elastase and gelatinase b are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid","volume":"204","author":"Shimanovich","year":"2004","journal-title":"J Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.matbio.2011.09.003","article-title":"Neutrophil elastase cleaves the murine hemidesmosomal protein BP180\/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid","volume":"31","author":"Lin","year":"2012","journal-title":"Matrix Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3693","article-title":"A critical role for neutrophil elastase in experimental bullous pemphigoid","volume":"105","author":"Liu","year":"2000","journal-title":"J Clin Invest"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01521.x","article-title":"Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid","volume":"117","author":"Verraes","year":"2001","journal-title":"J Invest Dermatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2019.1598759","article-title":"Life and death of circulating cell-free DNA","volume":"20","author":"Kustanovich","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41419-020-2497-x","article-title":"In vivo evidence for extracellular DNA trap formation","volume":"11","author":"Yousefi","year":"2020","journal-title":"Cell Death Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"17478","DOI":"10.1038\/s41598-020-74288-2","article-title":"Cell-free DNA in plasma as an essential immune system regulator","volume":"10","author":"Korabecna","year":"2020","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1215006109","article-title":"STING manifests self DNA-dependent inflammatory disease","volume":"109","author":"Ahn","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.10.017","article-title":"Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease","volume":"131","author":"Yang","year":"2007","journal-title":"Cell."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00201","article-title":"The role of eosinophils in bullous pemphigoid: A developing model of eosinophil pathogenicity in mucocutaneous disease","volume":"5","author":"Amber","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/all.13376","article-title":"Monocytes enhance neutrophil-induced blister formation in an ex vivo model of bullous pemphigoid","volume":"73","author":"de Graauw","year":"2018","journal-title":"Allergy."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00701","article-title":"NET formation in bullous pemphigoid patients with relapse is modulated by IL-17 and IL-23 interplay","volume":"10","author":"Giusti","year":"2019","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cytogfr.2010.09.001","article-title":"Interleukin-26: an IL-10-related cytokine produced by Th17 cells","volume":"21","author":"Donnelly","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001395","article-title":"IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation","volume":"10","author":"Corvaisier","year":"2012","journal-title":"PloS Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.130112","article-title":"The role of the novel Th17 cytokine IL-26 in intestinal inflammation","volume":"58","author":"Dambacher","year":"2009","journal-title":"Gut."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jid.2019.07.713","article-title":"Increased IL-26 expression promotes T helper type 17- and T helper type 2-associated cytokine production by keratinocytes in atopic dermatitis","volume":"140","author":"Kamijo","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.4.2006","article-title":"Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2","volume":"172","author":"Sheikh","year":"2004","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M405000200","article-title":"The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains","volume":"279","author":"H\u00f6r","year":"2004","journal-title":"J Biol Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.663192","article-title":"Serum interleukin-26 is a new biomarker for disease activity assessment in systemic lupus erythematosus","volume":"12","author":"Brilland","year":"2021","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600594","article-title":"IL-26 confers proinflammatory properties to extracellular DNA","volume":"198","author":"Poli","year":"2017","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15485","article-title":"Elevated circulating cell-free DNA levels in autoimmune bullous diseases","volume":"47","author":"Kakitsuka","year":"2020","journal-title":"J Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.06.032","article-title":"Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts","volume":"66","author":"Murrell","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.3357","article-title":"Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity","volume":"153","author":"van Beek","year":"2017","journal-title":"JAMA Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2018.30.5.544","article-title":"Circulating eosinophil and neutrophil counts correlate with disease severity in bullous pemphigoid","volume":"30","author":"Park","year":"2018","journal-title":"Ann Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16679","article-title":"Peripheral eosinophilia in bullous pemphigoid: prevalence and influence on the clinical manifestation","volume":"179","author":"Kridin","year":"2018","journal-title":"Br J Dermatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e22850","DOI":"10.1097\/MD.0000000000022850","article-title":"Clinical characteristics, mortality, and prognostic factors for bullous pemphigoid in a Thai population","volume":"99","author":"Amonchaisakda","year":"2020","journal-title":"Med (Baltimore)."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00204","article-title":"IL-26, a cytokine with roles in extracellular DNA-induced inflammation and microbial defense","volume":"10","author":"Larochette","year":"2019","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-3825","article-title":"IL26, a noncanonical mediator of DNA inflammatory stimulation, promotes TNBC engraftment and progression in association with neutrophils","volume":"80","author":"Trotter","year":"2020","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3211","article-title":"T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26","volume":"16","author":"Meller","year":"2015","journal-title":"Nat Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-013-0364-x","article-title":"Mechanisms regulating neutrophil survival and cell death","volume":"35","author":"Gabelloni","year":"2013","journal-title":"Semin Immunopathol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41467-020-20604-3","article-title":"Granzyme b inhibition reduces disease severity in autoimmune blistering diseases","volume":"12","author":"Hiroyasu","year":"2021","journal-title":"Nat Commun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.11.5397","article-title":"Cutting edge: immune cells as sources and targets of the IL-10 family members","volume":"168","author":"Wolk","year":"2002","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI99550","article-title":"IL-26 contributes to host defense against intracellular bacteria","volume":"129","author":"Dang","year":"2019","journal-title":"J Clin Invest."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01752","article-title":"BP180 is critical in the autoimmunity of bullous pemphigoid","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400095","article-title":"Bullous pemphigoid autoantibodies directly induce blister formation without complement activation","volume":"193","author":"Ujiie","year":"2014","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.11.029","article-title":"Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway","volume":"182","author":"Hiroyasu","year":"2013","journal-title":"Am J Pathol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/all.13131","article-title":"Evidence for a role of eosinophils in blister formation in bullous pemphigoid","volume":"72","author":"de Graauw","year":"2017","journal-title":"Allergy"},{"key":"B47","doi-asserted-by":"publisher","first-page":"936545","DOI":"10.1155\/2014\/936545","article-title":"Mediators of mast cells in bullous pemphigoid and dermatitis herpetiformis","volume":"2014","author":"Zebrowska","year":"2014","journal-title":"Mediators Inflamm"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.17.4.2877","article-title":"Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9","volume":"17","author":"Okada","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cyto.2012.01.009","article-title":"Potent synergistic effect of IL-3 and TNF on matrix metalloproteinase 9 generation by human eosinophils","volume":"58","author":"Kelly","year":"2012","journal-title":"Cytokine."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.01.078","article-title":"p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils","volume":"315","author":"Wiehler","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0151-1","article-title":"DNA Sensing by the cGAS-STING pathway in health and disease","volume":"20","author":"Motwani","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen","volume":"13","author":"Nishie","year":"2007","journal-title":"Nat Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903101","article-title":"A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen","volume":"184","author":"Ujiie","year":"2010","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J Autoimmun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402785","article-title":"Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes","volume":"194","author":"Ohnuma","year":"2015","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000870","article-title":"Interleukin-26, preferentially produced by T(H)17 lymphocytes, regulates CNS barrier function","volume":"7","author":"Broux","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01720.x","article-title":"Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin","volume":"118","author":"Sitaru","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.03.037","article-title":"Experimental laminin 332 mucous membrane pemphigoid critically involves C5aR1 and reflects clinical and immunopathological characteristics of the human disease","volume":"137","author":"Heppe","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041769","article-title":"Pathogenicity of autoantibodies in anti-p200 pemphigoid","volume":"7","author":"Vafia","year":"2012","journal-title":"PloS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1013382\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T15:25:58Z","timestamp":1677079558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1013382\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2022.1013382"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1013382","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"article-number":"1013382"}}